非酒精性脂肪性肝病与癌症发病率之间的关联
该历史性队列研究纳入2004年9月1日至2005年12月31日在韩国一家三级医院接受健康体检并随访超过1年的受试者,以超声诊断NAFLD,分析其与癌症发病的关联。中位随访7.5年期间,NAFLD组癌症发病率高于非NAFLD组(782.9 vs 592.8/10万人年;HR 1.32;95%CI 1.17-1.49;p<0.001)。调整人口学和代谢因素后,NAFLD与肝细胞癌、男性结直肠癌和女性乳腺癌风险升高相关,高NFS和高FIB-4评分与所有癌症及肝细胞癌发生强相关。
要点
- NAFLD组癌症发病率高于非NAFLD组(782.9 vs 592.8/10万人年;HR 1.32;95%CI 1.17-1.49;p<0.001)。
- 调整后NAFLD与肝细胞癌(HR 16.73;95%CI 2.09-133.85;p=0.008)相关。
- 调整后NAFLD与男性结直肠癌(HR 2.01;95%CI 1.10-3.68;p=0.02)和女性乳腺癌(HR 1.92;95%CI 1.15-3.20;p=0.01)相关。
核心结论
- NAFLD与肝细胞癌、男性结直肠癌和女性乳腺癌的发生相关。
- 高NFS和高FIB-4评分与所有癌症及肝细胞癌的发生强相关。
研究设计与样本
- 历史性队列研究,纳入2004年9月1日至2005年12月31日在韩国一家三级医院接受健康体检并随访超过1年的受试者,共25,947例,其中8,721例(33.6%)患有NAFLD,NAFLD经超声检测肝脂肪变且无其他已知肝病(包括酒精性或病毒性肝炎)诊断。
- 采用Cox比例风险回归模型评估NAFLD与癌症发生的关联。
主要发现
- 总随访164,671人年(中位7.5年)期间,NAFLD组癌症发病率高于非NAFLD组(782.9 vs 592.8/10万人年;HR 1.32;95%CI 1.17-1.49;p<0.001)。
- 调整人口学和代谢因素后,NAFLD与肝细胞癌发生相关(HR 16.73;95%CI 2.09-133.85;p=0.008)。
- 调整人口学和代谢因素后,NAFLD与男性结直肠癌发生相关(HR 2.01;95%CI 1.10-3.68;p=0.02)。
- 调整人口学和代谢因素后,NAFLD与女性乳腺癌发生相关(HR 1.92;95%CI 1.15-3.20;p=0.01)。
- 高NFS和高FIB-4评分与所有癌症及肝细胞癌的发生强相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Little is known about the association between non-alcoholic fatty liver disease (NAFLD) and cancer development. This study investigated the cancer incidence rates in NAFLD and analysed the association between NAFLD and cancer development. METHODS: This historical cohort study included subjects who were followed up for >1 year after having a heath checkup at a tertiary hospital in Korea from September 1, 2004 to December 31, 2005. NAFLD was diagnosed by ultrasonographic detection of hepatic steatosis in the absence of other known liver disease, including alcoholic or viral hepatitis. Cox proportional hazards regression model was conducted to assess the association between NAFLD and cancer development. RESULTS: Of 25,947 subjects, 8,721 (33.6%) had NAFLD. During the total follow-up of 164,671 person-years (median 7.5 years), the cancer incidence rate of the NAFLD group was higher than that of the non-NAFLD group (782.9 vs. 592.8 per 100,000 person-years; hazard ratio [HR] 1.32; 95% confidence interval [CI] 1.17-1.49; p <0.001). When demographic and metabolic factors were adjusted for, NAFLD showed a strong association with three cancers: hepatocellular carcinoma ([HCC]; HR 16.73; 95% CI 2.09-133.85; p = 0.008), colorectal cancer in males (HR 2.01; 95% CI 1.10-3.68; p = 0.02), and breast cancer in females (HR 1.92; 95% CI 1.15-3.20; p = 0.01). A high NAFLD fibrosis score (NFS) and a high fibrosis-4 (FIB-4) score were associated with the development of all cancers and HCC. CONCLUSION: NAFLD was associated with the development of HCC, colorectal cancer in males, and breast cancer in females. A high NFS and a high FIB-4 score showed a strong association with the development of all cancers and HCC. LAY SUMMARY: Non-alcoholic fatty liver disease (NAFLD) is associated with developing hepatocellular carcinoma (HCC). There have been limited data on the association between NAFLD and extrahepatic cancers. This study demonstrated that patients with NAFLD showed a higher association with the development of HCC, colorectal cancer in males, and breast cancer in females. A high NAFLD fibrosis score and a high fibrosis-4 score showed a strong association with the development of all cancers and HCC.
引用
- Kim GA, Lee HC, Choe J, et al. Association between non-alcoholic fatty liver disease and cancer incidence rate. J Hepatol. 2017. PMID: 29150142. doi:10.1016/j.jhep.2017.09.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。